These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 627747)

  • 1. Behçet's disease: possible role of secretory component deficiency, synovial inclusions, and fibrinolytic abnormality in the various manifestations of the disease.
    Abdou NI; Schumacher HR; Colman RW; Sagawa A; Hebert J; Pascual E; Carroll ET; Miller M; South MA; Abdou NL
    J Lab Clin Med; 1978 Mar; 91(3):409-22. PubMed ID: 627747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis.
    Adişen E; Aral A; Aybay C; Gürer MA
    Dermatology; 2008; 217(3):235-40. PubMed ID: 18663306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory component deficiency. A disorder of the IgA immune system.
    Strober W; Krakauer R; Klaeveman HL; Reynolds HY; Nelson DL
    N Engl J Med; 1976 Feb; 294(7):351-6. PubMed ID: 1107842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease.
    Akman A; Sallakci N; Coskun M; Bacanli A; Yavuzer U; Alpsoy E; Yegin O
    Br J Dermatol; 2006 Aug; 155(2):350-6. PubMed ID: 16882174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins.
    Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G
    Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease.
    Hamzaoui K; Hamzaoui A; Zakraoui L; Chabbou A
    Mediators Inflamm; 1999; 8(2):101-6. PubMed ID: 10704147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peculiar secretory IgA system identified in chickens. II. Identification and distribution of free secretory component and immunoglobulins of IgA, IgM, and IgG in chicken external secretions.
    Watanabe H; Kobayashi K; Isayama Y
    J Immunol; 1975 Oct; 115(4):998-1001. PubMed ID: 1176771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory component deficiency in Behçet's disease.
    Hamza M; Makni S
    Clin Rheumatol; 1995 Mar; 14(2):227-8. PubMed ID: 7789068
    [No Abstract]   [Full Text] [Related]  

  • 11. T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease.
    Pervin K; Childerstone A; Shinnick T; Mizushima Y; van der Zee R; Hasan A; Vaughan R; Lehner T
    J Immunol; 1993 Aug; 151(4):2273-82. PubMed ID: 7688396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligoclonal B lymphocyte expansion in the synovium of a patient with Behçet's disease.
    Suh CH; Park YB; Song J; Lee CH; Lee SK
    Arthritis Rheum; 2001 Jul; 44(7):1707-12. PubMed ID: 11465723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12.
    Frassanito MA; Dammacco R; Cafforio P; Dammacco F
    Arthritis Rheum; 1999 Sep; 42(9):1967-74. PubMed ID: 10513814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin activatable fibrinolysis inhibitor in Behçet's disease.
    Donmez A; Aksu K; Celik HA; Keser G; Cagirgan S; Omay SB; Inal V; Aydin HH; Tombuloglu M; Doganavsargil E
    Thromb Res; 2005; 115(4):287-92. PubMed ID: 15668188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of gammadelta T-cells in Behçet's disease: role of disease activity and microbial flora in oral ulcers.
    Bank I; Duvdevani M; Livneh A
    J Lab Clin Med; 2003 Jan; 141(1):33-40. PubMed ID: 12518166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of allantoin levels as a new marker of oxidative stress in Behçet's disease.
    Yardim-Akaydin S; Sepici A; Ozkan Y; Simşek B; Sepici V
    Scand J Rheumatol; 2006; 35(1):61-4. PubMed ID: 16467045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characteristics of B cells in Behçet's disease: increased activity in B cell subsets.
    Ekşioglu-Demiralp E; Kibaroglu A; Direskeneli H; Yavuz S; Karsli F; Yurdakul S; Yazici H; Akoglu T
    J Rheumatol; 1999 Apr; 26(4):826-32. PubMed ID: 10229403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity assessment using comet assay in Behcet's disease patients.
    Bilgici B; Bedir A; Sentürk N; Alvur M; Aydin F; Turanli AY
    Mutat Res; 2005 Oct; 578(1-2):170-4. PubMed ID: 16019038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokine profiles in Behçet's disease: is there a role for IL-15 in pathogenesis?
    Curnow SJ; Pryce K; Modi N; Knight B; Graham EM; Stewart JE; Fortune F; Stanford MR; Murray PI; Wallace GR
    Immunol Lett; 2008 Nov; 121(1):7-12. PubMed ID: 18706446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immune status and microphage function in Behçet's disease].
    Djawari D; Hornstein OP
    Z Hautkr; 1980 Mar; 55(5):271-92. PubMed ID: 6996366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.